Syngene
Live Price
Recent news and updates for SYNGENE will appear here soon.
"Caution advised for SYNGENE investors. AI signals correlate with a sustained bearish trend. Technical indicators suggest further consolidation within the healthcare sector before a reliable long-term bottom is established."
Verified by Stockmo Intelligence Grid
Citing cross-referenced internal documents and market technicals
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and analytical chemistry; discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals; and chemical, formulation, analytical, and clinical development services. It provides lead generation, preclinical development, API, and drug product development services; and clinical trial management, pharmacokinetic analysis/bioanalytical studies, biometrics and clinical data management, central lab, regulatory, medical monitoring, pharmacovigilance, and medical writing services. In addition, the company offers chemistry, biology, safety assessment, computational, and data sciences for traditional small molecule therapeutics; biologics; and specialty modalities, such as peptides, oligonucleotides, antibody-drug conjugates, and targeted degradation/stabilization. It serves pharmaceutical, biotechnology, animal health, nutrition, consumer goods, agrochemical, performance and specialty materials, and other companies. The company has collaborations with Bristol-Myers Squibb, Baxter Inc., and Amgen Inc. The company was incorporated in 1993 and is headquartered in Bengaluru, India. Syngene International Limited is a subsidiary of Biocon Limited.
As of the latest market session, Syngene (SYNGENE) is trading at ₹380.6, representing a move of 0.46% from the previous close.
Syngene is listed and traded under the ticker symbol SYNGENE on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Syngene's stock price moved by 0.46%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 25% bullish probability for SYNGENE stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Syngene shares reached a high of ₹678.95 and hit a low of ₹374.2.
SYNGENE exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 1,39,748 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Syngene has a market capitalization of ₹15319.27 Cr, designating its size class inside the Healthcare sector.
Syngene has a current dividend yield of 33.00%. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Syngene's trailing Price-to-Earnings (P/E) ratio is 69.58. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Syngene (SYNGENE) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Syngene's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore SYNGENE's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for SYNGENE are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Syngene operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.